Neuroinflammatory conditions

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial

Study Overview The clinical trial investigated the use of hyaluronidase-facilitated subcutaneous immunoglobulin (Ig) 10% as a long-term maintenance therapy for […]

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial Read Post »

Reply to the Letter “Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barre Syndrome of a Severe Refractory Case”

Clinical Presentation The clinical manifestation of acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) often overlaps with conditions such as Guillain-Barré Syndrome

Reply to the Letter “Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barre Syndrome of a Severe Refractory Case” Read Post »

Transcriptomic profiling and structural characterization reveal UQCRC1 and COX4I1 as key mitochondrial regulators associated with oxidative stress in multiple sclerosis

Key Mitochondrial Regulators Identified The exploration of mitochondrial biology has unveiled crucial components that play significant roles in cellular metabolism

Transcriptomic profiling and structural characterization reveal UQCRC1 and COX4I1 as key mitochondrial regulators associated with oxidative stress in multiple sclerosis Read Post »

Scroll to Top